Clinical Trial Site

Pasadena, California 91107

1 studies enrolling now · 5 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria (AIP), Chronic Hepatitis B, Hepatic Porphyrias, Hereditary Coproporphyria (HCP), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Non-infectious Intermediate Uveitis, Non-infectious Pan Uveitis, Non-infectious Posterior Uveitis

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis — Completed
• Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B — Stopped early
• INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP — Stopped early